Human polyomavirus reactivation: Disease pathogenesis and treatment approaches

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  De Gascun, Cillian F ^a   Carr, Michael J ^b  

^a FRIMLEY PARK HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD34 ANTIGEN; CIDOFOVIR; CYTARABINE; LEFLUNOMIDE; MEFLOQUINE; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; VASCULAR CELL ADHESION MOLECULE 1; VIRUS T ANTIGEN; ANTIVIRUS AGENT; VIRUS RNA;

ANTIVIRAL THERAPY; BK VIRUS; DISEASE ASSOCIATION; DNA REPLICATION; HEMORRHAGIC CYSTITIS; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; JC VIRUS; KIDNEY DISEASE; MERKEL CELL POLYOMAVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; URETER OBSTRUCTION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION; BIOSYNTHESIS; CLASSIFICATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNE EVASION; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; PHYLOGENY; POLYOMA VIRUS; VIROLOGY; VIRUS ACTIVATION; VIRUS GENOME; VIRUS INFECTION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

ANTIVIRAL AGENTS; BK VIRUS; GENOME, VIRAL; HUMANS; IMMUNE EVASION; IMMUNE SYSTEM; IMMUNOCOMPROMISED HOST; JC VIRUS; PHYLOGENY; POLYOMAVIRIDAE; POLYOMAVIRUS INFECTIONS; RNA, VIRAL; TUMOR VIRUS INFECTIONS; VIRUS ACTIVATION;

EID: 84877932972     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/373579     Document Type: Review

References (331)

1. Feltkamp M. C., Kazem S., van der Meijden E., From Stockholm to Malawi: recent developments in studying human polyomaviruses. Journal of General Virology 2013 94, part 3 482 496
2. Allander T., Andreasson K., Gupta S., Bjerkner A., Bogdanovic G., Persson M. A. A., Dalianis T., Ramqvist T., Andersson B., Identification of a third human polyomavirus. Journal of Virology 2007 81 8 4130 4136 2-s2.0-34247158281 10.1128/JVI.00028-07 (Pubitemid 46586907)
3. Gaynor A. M., Nissen M. D., Whiley D. M., Mackay I. M., Lambert S. B., Wu G., Brennan D. C., Storch G. A., Sloots T. P., Wang D., Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathogens 2007 3 5, article e64 2-s2.0-34249650137 10.1371/journal.ppat.0030064 (Pubitemid 46827944)
4. Feng H., Shuda M., Chang Y., Moore P. S., Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008 319 5866 1096 1100 2-s2.0-39749113080 10.1126/science.1152586 (Pubitemid 351300792)
5. Schowalter R. M., Pastrana D. V., Pumphrey K. A., Moyer A. L., Buck C. B., Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host and Microbe 2010 7 6 509 515 2-s2.0-77956506650 10.1016/j.chom.2010.05.006
6. van der Meijden E., Janssens R. W., Lauber C., Bouwes Bavinck J. N., Gorbalenya A. E., Feltkamp M. C., Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathogens 2010 6 7 e1001024 2-s2.0-77958128563 10.1371/journal.ppat.1001024
7. Scuda N., Hofmann J., Calvignac-Spencer S., Ruprecht K., Liman P., Kühn J., Hengel H., Ehlers B., A novel human polyomavirus closely related to the African green monkey-derived lymphotropic polyomavirus. Journal of Virology 2011 85 9 4586 4590 2-s2.0-79955429137 10.1128/JVI.02602-10
8. Buck C. B., Phan G. Q., Raiji M. T., Complete genome sequence of a tenth human polyomavirus. Journal of Virology 2012 86 19 10887
9. Siebrasse E. A., Reyes A., Lim E. S., Identification of MW polyomavirus, a novel polyomavirus in human stool. Journal of Virology 2012 86 19 10321 10326
10. Padgett B. L., Walker D. L., ZuRhein G. M., Eckroade R. J., Dessel B. H., Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. The Lancet 1971 1 7712 1257 1260 2-s2.0-0015232447
11. Gardner S. D., Field A. M., Coleman D. V., Hulme B., New human papovavirus (B.K.) isolated from urine after renal transplantation. The Lancet 1971 1 7712 1253 1257 2-s2.0-0015232481
12. Kean J. M., Rao S., Wang M., Garcea R. L., Seroepidemiology of human polyomaviruses. PLoS Pathogens 2009 5 3 e1000363 2-s2.0-63449123993 10.1371/journal.ppat.1000363
13. Bennett S. M., Broekema N. M., Imperiale M. J., BK polyomavirus: emerging pathogen. Microbes and Infection 2012 14 9 672 683
14. Major E. O., Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annual Review of Medicine 2010 61 35 47 2-s2.0-77949375380 10.1146/annurev.med.080708.082655
15. Carson K. R., Focosi D., Major E. O., Petrini M., Richey E. A., West D. P., Bennett C. L., Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. The Lancet Oncology 2009 10 8 816 824 2-s2.0-67651158993 10.1016/S1470-2045(09)70161-5
16. Kleinschmidt-DeMasters B. K., Tyler K. L., Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. The New England Journal of Medicine 2005 353 4 369 374 2-s2.0-22844439662 10.1056/NEJMoa051782 (Pubitemid 41132341)
17. Van Assche G., Van Ranst M., Sciot R., Dubois B., Vermeire S., Noman M., Verbeeck J., Geboes K., Robberecht W., Rutgeerts P., Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. The New England Journal of Medicine 2005 353 4 362 368 2-s2.0-22844445587 10.1056/NEJMoa051586 (Pubitemid 41132340)
18. Carson K. R., Evens A. M., Richey E. A., Habermann T. M., Focosi D., Seymour J. F., Laubach J., Bawn S. D., Gordon L. I., Winter J. N., Furman R. R., Vose J. M., Zelenetz A. D., Mamtani R., Raisch D. W., Dorshimer G. W., Rosen S. T., Muro K., Gottardi-Littell N. R., Talley R. L., Sartor O., Green D., Major E. O., Bennett C. L., Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009 113 20 4834 4840 2-s2.0-66549130454 10.1182/blood-2008-10-186999
19. Sobell J. M., Weinberg J. M., Patient fatalities potentially associated with efalizumab use. Journal of Drugs in Dermatology 2009 8 3 215 2-s2.0-63249131674
20. Kumar D., Bouldin T. W., Berger R. G., A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. Arthritis and Rheumatism 2010 62 11 3191 3195 2-s2.0-78249286239 10.1002/art.27687
21. Delbue S., Comar M., Ferrante P., Review on the relationship between human polyomaviruses-associated tumors and host immune system. Clinical and Developmental Immunology 2012 2012 10 542092 10.1155/2012/542092
22. Stewart S. E., Eddy B. E., Borgese N., Neoplasms in mice inoculated with a tumor agent carried in tissue. Journal of the National Cancer Institute 1958 20 6 1223 1243 2-s2.0-0001001267
23. Ferenczy M. W., Marshall L. J., Nelson C. D., Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clinical Microbiology Reviews 2012 25 3 471 506
24. Abend J. R., Joseph A. E., Das D., Campbell-Cecen D. B., Imperiale M. J., A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. Journal of General Virology 2009 90 5 1238 1245 2-s2.0-67449083276 10.1099/vir.0.009159-0
25. Darbinyan A., Siddiqui K. M., Slonina D., Darbinian N., Amini S., White M. K., Khalili K., Role of JC virus agnoprotein in DNA repair. Journal of Virology 2004 78 16 8593 8600 2-s2.0-3543072183 10.1128/JVI.78.16.8593-8600.2004 (Pubitemid 39025125)
26. Khalili K., White M. K., Sawa H., Nagashima K., Safak M., The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. Journal of Cellular Physiology 2005 204 1 1 7 2-s2.0-20144370475 10.1002/jcp.20266 (Pubitemid 40776801)
27. Safak M., Khalili K., Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. Journal of NeuroVirology 2001 7 4 288 292 2-s2.0-0034827329 10.1080/13550280152537111 (Pubitemid 32894229)
28. Suzuki T., Orba Y., Okada Y., Sunden Y., Kimura T., Tanaka S., Nagashima K., Hall W. W., Sawa H., The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathogens 2010 6 3 2-s2.0-77950444850 10.1371/journal.ppat. 1000801 e1000801
29. Åström K. E., Mancall E. L., Richardson E. P. Jr., Progressive multifocal leuko-encephalopathy: a HITHERTO unrecognized COMPLICATION o CHRONIC lymphatic leukÆmia AND hodgkin's disease. Brain 1958 81 1 93 111 2-s2.0-77957184066 10.1093/brain/81.1.93
30. Christensen E., Fog M., A case of Schilder's disease in an adult with remarks to the etiology and pathogenesis. Acta Psychiatrica et Neurologica Scandinavica 1955 30 1-2 141 154 2-s2.0-53349150721
31. Richardson E. P. Jr., Progressive multifocal leukoencephalopathy. The New England Journal of Medicine 1961 265 815 823 2-s2.0-0000972837
32. Cavanagh J. B., Greenbaum D., Marshall A. H. E., Rubinstein L. J., Cerebral demyelination associated with disorders of the reticuloendothelial system. The Lancet 1959 274 7102 524 529 2-s2.0-0001777796
33. Osborn J. E., Robertson S. M., Padgett B. L., Comparison of JC and BK human papovaviruses with Simian virus 40: restriction endonuclease digestion and gel electrophoresis of resultant fragments. Journal of Virology 1974 13 3 614 622 2-s2.0-0016366739
34. Brown P., Tsai T., Gajdusek D. C., Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. American Journal of Epidemiology 1975 102 4 331 340 2-s2.0-0016786263
35. Rziha H. J., Bornkamm G. W., zur Hausen H., BK virus. I. Seroepidemiologic studies and serologic response to viral infection. Medical Microbiology and Immunology 1978 165 2 73 81 2-s2.0-0018194489 (Pubitemid 8360281)
36. Walker D. L., Padgett B. L., The epidemiology of human polyomaviruses. Progress in Clinical and Biological Research 1983 105 99 106 2-s2.0-0020689850
37. Knowles W. A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D. W. G., Miller E., Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. Journal of Medical Virology 2003 71 1 115 123 2-s2.0-0141459365 10.1002/jmv.10450 (Pubitemid 37121921)
38. Lundstig A., Dillner J., Serological diagnosis of human polyomavirus infection. Advances in Experimental Medicine and Biology 2006 577 96 101 2-s2.0-33745585847 10.1007/0-387-32957-9-7
39. Stolt A., Sasnauskas K., Koskela P., Lehtinen M., Dillner J., Seroepidemiology of the human polyomaviruses. Journal of General Virology 2003 84 6 1499 1504 2-s2.0-0038654083 10.1099/vir.0.18842-0 (Pubitemid 36675520)
40. Major E. O., Neel J. V., The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: there is no serological evidence of cross-reactivity with the simian polyoma virus SV40. Proceedings of the National Academy of Sciences of the United States of America 1998 95 26 15525 15530 2-s2.0-0032417620 (Pubitemid 29018732)
41. Ahmed W., Wan C., Goonetilleke A., Gardner T., Evaluating sewage-associated JCV and BKV polyomaviruses for sourcing human fecal pollution in a coastal river in Southeast Queensland, Australia. Journal of Environmental Quality 2010 39 5 1743 1750 2-s2.0-77957874611 10.2134/jeq2010.0062
42. Hamza I. A., Jurzik L., Stang A., Sure K., Überla K., Wilhelm M., Detection of human viruses in rivers of a densly-populated area in Germany using a virus adsorption elution method optimized for PCR analyses. Water Research 2009 43 10 2657 2668 2-s2.0-65549131861 10.1016/j.watres.2009.03.020
43. McQuaig S. M., Scott T. M., Lukasik J. O., Paul J. H., Harwood V. J., Quantification of human polyomaviruses JC virus and BK Virus by TaqMan quantitative PCR and comparison to other water quality indicators in water and fecal samples. Applied and Environmental Microbiology 2009 75 11 3379 3388 2-s2.0-66249090524 10.1128/AEM.02302-08
44. Vanchiere J. A., Abudayyeh S., Copeland C. M., Lu L. B., Graham D. Y., Butel J. S., Polyomavirus shedding in the stool of healthy adults. Journal of Clinical Microbiology 2009 47 8 2388 2391 2-s2.0-68549086973 10.1128/JCM.02472-08
45. Vanchiere J. A., Nicome R. K., Greer J. M., Demmler G. J., Butel J. S., Frequent detection of polyomaviruses in stool samples from hospitalized children. Journal of Infectious Diseases 2005 192 4 658 664 2-s2.0-23244433559 10.1086/432076 (Pubitemid 41099315)
46. Cubitt C. L., Cui X., Agostini H. T., Nerurkar V. R., Scheirich I., Yanagihara R., Ryschkewitsch C. F., Stoner G. L., Predicted amino acid sequences for 100 JCV strains. Journal of NeuroVirology 2001 7 4 339 344 2-s2.0-0034827332 10.1080/13550280152537201 (Pubitemid 32894238)
47. Agostini H. T., Yanagihara R., Davis V., Ryschkewitsch C. F., Stoner G. L., Asian genotypes of JC virus in native Americans and in a Pacific Island population: markers of viral evolution and human migration. Proceedings of the National Academy of Sciences of the United States of America 1997 94 26 14542 14546 2-s2.0-0031446337 10.1073/pnas.94.26.14542 (Pubitemid 28041410)
48. Ikegaya H., Zheng H. Y., Saukko P. J., Varesmaa-Korhonen L., Hovi T., Vesikari T., Suganami H., Takasaka T., Sugimoto C., Ohasi Y., Kitamura T., Yogo Y., Genetic diversity of JC virus in the Saami and the Finns: implications for their population history. American Journal of Physical Anthropology 2005 128 1 185 193 2-s2.0-21444460295 10.1002/ajpa.20189 (Pubitemid 41216070)
49. Ryschkewitsch C. F., Friedlaender J. S., Mgone C. S., Jobes D. V., Agostini H. T., Chima S. C., Alpers M. P., Koki G., Yanagihara R., Stoner G. L., Human polyomavirus JC variants in Papua New Guinea and Guam reflect ancient population settlement and viral evolution. Microbes and Infection 2000 2 9 987 996 2-s2.0-0033843077 10.1016/S1286-4579(00)01252-1 (Pubitemid 30664212)
50. Stoner G. L., Jobes D. V., Fernandez Cobo M., Agostini H. T., Chima S. C., Ryschkewitsch C. F., JC virus as a marker of human migration to the Americas. Microbes and Infection 2000 2 15 1905 1911 2-s2.0-0034500384 10.1016/S1286-4579(00)01339-3 (Pubitemid 32063542)
51. Pavesi A., African origin of polyomavirus JC and implications for prehistoric human migrations. Journal of Molecular Evolution 2003 56 5 564 572 2-s2.0-0037403373 10.1007/s00239-002-2425-y (Pubitemid 36418984)
52. Cui X., Wang J. C., Deckhut A., Joseph B. C., Eberwein P., Cubitt C. L., Ryschkewitsch C. F., Agostini H. T., Stoner G. L., Chinese strains (type 7) of JC virus are Afro-Asiatic in origin but are phylogenetically distinct from the Mongolian and Indian strains (type 2D) and the Korean and Japanese strains (type 2A). Journal of Molecular Evolution 2004 58 5 568 583 2-s2.0-2342601791 10.1007/s00239-003-2579-2 (Pubitemid 38609892)
53. Jobes D. V., Friedlaender J. S., Mgone C. S., Agostini H. T., Koki G., Yanagihara R., Ng T. C. N., Chima S. C., Ryschkewitsch C. F., Stoner G. L., New JC virus (JCV) genotypes from Papua New Guinea and Micronesia (type 8 and type 2E) and evolutionary analysis of 32 complete JCV genomes. Archives of Virology 2001 146 11 2097 2113 2-s2.0-0035211486 10.1007/s007050170023 (Pubitemid 33145581)
54. Yanagihara R., Nerurkar V. R., Scheirich I., Agostini H. T., Mgone C. S., Cui X., Jobes D. V., Cubitt C. L., Ryschkewitsch C. F., Hrdy D. B., Friedlaender J. S., Stoner G. L., JC virus genotypes in the western Pacific suggest Asian mainland relationships and virus association with early population movements. Human Biology 2002 74 3 473 488 2-s2.0-0036023270 (Pubitemid 34869566)
55. Agostini H. T., Ryschkewitsch C. F., Baumhefner R. W., Tourtellotto W. W., Singer E. J., Komoly S., Stoner G. L., Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy. Journal of NeuroVirology 2000 6 supplement 2 S101 S108 2-s2.0-0034129457 (Pubitemid 30348922)
56. Dubois V., Moret H., Lafon M. E., Brodard V., Icart J., Ruffault A., Guist'hau O., Buffet-Janvresse C., Abbed K., Dussaix E., Ingrand D., JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. Journal of Infectious Diseases 2001 183 2 213 217 2-s2.0-0035863569 10.1086/317927 (Pubitemid 32066021)
57. Monaco M. C. G., Atwood W. J., Gravell M., Tornatore C. S., Major E. O., JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: Implications for viral latency. Journal of Virology 1996 70 10 7004 7012 2-s2.0-0029794531 (Pubitemid 26307415)
58. Houff S. A., Major E. O., Katz D. A., Kufta C. V., Sever J. L., Pittaluga S., Roberts J. R., Gitt J., Saini N., Lux W., Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. The New England Journal of Medicine 1988 318 5 301 305 2-s2.0-0023860204 (Pubitemid 18034522)
59. Haider S., Nafziger D., Gutierrez J. A., Brar I., Mateo N., Fogle J., Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases. Clinical Infectious Diseases 2000 31 4 E20 E22 2-s2.0-18044393264
60. Puri V., Chaudhry N., Gulati P., Patel N., Tatke M., Sinha S., Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+T lymphocytopenia. Neurology India 2010 58 1 118 121 2-s2.0-77949619394 10.4103/0028-3886.60423
61. Du Pasquier R. A., Kuroda M. J., Zheng Y., Jean-Jacques J., Letvin N. L., Koralnik I. J., A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004 127 9 1970 1978 2-s2.0-4344600302 10.1093/brain/awh215 (Pubitemid 39150256)
62. Marzocchetti A., Tompkins T., Clifford D. B., Gandhi R. T., Kesari S., Berger J. R., Simpson D. M., Prosperi M., De Luca A., Koralnik I. J., Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009 73 19 1551 1558 2-s2.0-72049104419 10.1212/WNL.0b013e3181c0d4a1
63. D'Arminio Monforte A., Cinque P., Mocroft A., Goebel F. D., Antunes F., Katlama C., Justesen U. S., Vella S., Kirk O., Lundgren J., Changing incidence of central nervous system diseases in the EuroSIDA cohort. Annals of Neurology 2004 55 3 320 328 2-s2.0-10744220788 10.1002/ana.10827 (Pubitemid 38292033)
64. Khanna N., Elzi L., Mueller N. J., Garzoni C., Cavassini M., Fux C. A., Vernazza P., Bernasconi E., Battegay M., Hirsch H. H., Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the swiss HIV cohort study. Clinical Infectious Diseases 2009 48 10 1459 1466 2-s2.0-65549125336 10.1086/598335
65. Amend K. L., Turnbull B., Foskett N., Napalkov P., Kurth T., Seeger J., Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 2010 75 15 1326 1332 2-s2.0-77958572934 10.1212/WNL.0b013e3181f73600
66. Palazzo E., Yahia S. A., Progressive multifocal leukoencephalopathy in autoimmune diseases. Joint Bone Spine 2012 79 4 351 355
67. Arkema E. V., van Vollenhoven R. F., Askling J., Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study. Annals of the Rheumatic Diseases 2012 71 11 1865 1867
68. Bloomgren G., Richman S., Hotermans C., Risk of natalizumab-associated progressive multifocal leukoencephalopathy. The New England Journal of Medicine 2012 366 20 1870 1880
69. Mateen F. J., Muralidharan R., Carone M., Progressive multifocal leukoencephalopathy in transplant recipients. Annals of Neurology 2011 70 2 305 322
70. Atwood W. J., Amemiya K., Traub R., Harms J., Major E. O., Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 1992 190 2 716 723 2-s2.0-0026775246 10.1016/0042-6822(92)90909-9
71. Major E. O., Amemiya K., Elder G., Houff S. A., Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. Journal of Neuroscience Research 1990 27 4 461 471 2-s2.0-0025606931 10.1002/jnr.490270405
72. Rieckmann P., Michel U., Kehrl J. H., Regulation of JC virus expression in B lymphocytes. Journal of Virology 1994 68 1 217 222 2-s2.0-0027976781
73. Tornatore C., Berger J. R., Houff S. A., Curfman B., Meyers K., Winfield D., Major E. O., Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Annals of Neurology 1992 31 4 454 462 2-s2.0-0026751053 10.1002/ana.410310426
74. Major E. O., History and current concepts in the pathogenesis of PML. Cleveland Clinic Journal of Medicine 2011 78, supplement 2 S3 S7
75. Bayliss J., Karasoulos T., Bowden S., Immunosuppression increases latent infection of brain by JC polyomavirus. Pathology 2011 43 4 362 367
76. Delbue S., Branchetti E., Boldorini R., Vago L., Zerbi P., Veggiani C., Tremolada S., Ferrante P., Presence and expression of JCV early gene large T antigen in the brains of immunocompromised and immunocompetent individuals. Journal of Medical Virology 2008 80 12 2147 2152 2-s2.0-57349131082 10.1002/jmv.21313
77. Perez-Liz G., Del Valle L., Gentilella A., Croul S., Khalili K., Detection of JC virus DNA fragments but not proteins in normal brain tissue. Annals of Neurology 2008 64 4 379 387 2-s2.0-55849085378 10.1002/ana.21443
78. Tan C. S., Ellis L. C., Wüthrich C., Ngo L., Broge T. A., Saint-Aubyn J., Miller J. S., Koralnik I. J., JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. Journal of Virology 2010 84 18 9200 9209 2-s2.0-77956044326 10.1128/JVI.00609-10
79. Monaco M. C. G., Jensen P. N., Hou J., Durham L. C., Major E. O., Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. Journal of Virology 1998 72 12 9918 9923 2-s2.0-0031798275 (Pubitemid 28520858)
80. Fiers W., Contreras R., Haegeman G., Complete nucleotide sequence of SV40 DNA. Nature 1978 273 5658 113 120 2-s2.0-0017796985 (Pubitemid 8322604)
81. Frisque R. J., Nucleotide sequence of the region encompassing the JC virus origin of DNA replication. Journal of Virology 1983 46 1 170 176 2-s2.0-0020693742 (Pubitemid 13161256)
82. Frisque R. J., Bream G. L., Cannella M. T., Human polyomavirus JC virus genome. Journal of Virology 1984 51 2 458 469 2-s2.0-0021242613 (Pubitemid 14091437)
83. Law M. F., Martin J. D., Takemoto K. K., Howley P. M., The colinear alignment of the genomes of papovaviruses JC, BK, and SV40. Virology 1979 96 2 576 587 2-s2.0-0018748397 (Pubitemid 9236695)
84. Reddy V. B., Thimmappaya B., Dhar R., The genome of Simian virus 40. Science 1978 200 4341 494 502 2-s2.0-0017837667 (Pubitemid 8328379)
85. Seif I., Khoury G., Dhar R., The genome of human papovavirus BKV. Cell 1979 18 4 963 977 2-s2.0-0018611461 (Pubitemid 10172635)
86. Yang R. C. A., Wu R., Comparative study of papovavirus DNA: BKV(MM), BKV(WT) and SV40. Nucleic Acids Research 1979 7 3 651 668 2-s2.0-0018681489 (Pubitemid 10246797)
87. Ghosh P. K., Lebowitz P., Frisque R. J., Gluzman Y., Identification of a promoter component involved in positioning the 5' termini of simian virus 40 early mRNAs. Proceedings of the National Academy of Sciences of the United States of America 1981 78 1 100 104 2-s2.0-0019519795 (Pubitemid 11131247)
88. Gluzman Y., Sambrook J. F., Frisque R. J., Expression of early genes of origin-defective mutants of simian virus 40. Proceedings of the National Academy of Sciences of the United States of America 1980 77 7 3898 3902 2-s2.0-2042445974 (Pubitemid 10015487)
89. Frisque R. J., Regulatory sequences and virus-cell interactions of JC virus. Progress in Clinical and Biological Research 1983 105 41 59 2-s2.0-0020651757
90. Lynch K. J., Frisque R. J., Identification of critical elements within the JC virus DNA replication origin. Journal of Virology 1990 64 12 5812 5822 2-s2.0-0025202687
91. Martin J. D., King D. M., Slauch J. M., Differences in regulatory sequences of naturally occurring JC virus variants. Journal of Virology 1985 53 1 306 311 (Pubitemid 15194972)
92. Yogo Y., Kitamura T., Sugimoto C., Ueki T., Aso Y., Hara K., Taguchi F., Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. Journal of Virology 1990 64 6 3139 3143 2-s2.0-0025302980 (Pubitemid 20171319)
93. Jensen P. N., Major E. O., Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. Journal of Leukocyte Biology 1999 65 4 428 438 2-s2.0-0032927206 (Pubitemid 29160169)
94. Marzocchetti A., Wuthrich C., Tan C. S., Tompkins T., Bernal-Cano F., Bhargava P., Ropper A. H., Koralnik I. J., Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. Journal of NeuroVirology 2008 14 5 455 458 2-s2.0-57049182365 10.1080/13550280802356837 (Pubitemid 352762885)
95. Vaz B., Cinque P., Pickhardt M., Weber T., Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. Journal of NeuroVirology 2000 6 5 398 409 2-s2.0-0033813018
96. Flaegstad T., Sundsfjord A., Arthur R. R., Pedersen M., Traavik T., Subramani S., Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 1991 180 2 553 560 2-s2.0-0025977571 10.1016/0042-6822(91)90069-N
97. Iida T., Kitamura T., Guo J., Taguchi F., Aso Y., Nagashima K., Yogo Y., Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proceedings of the National Academy of Sciences of the United States of America 1993 90 11 5062 5065 2-s2.0-0027217678 (Pubitemid 23182976)
98. Dorries K., Vogel E., Gunther S., Czub S., Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994 198 2 59 70 2-s2.0-0028239405
99. Schneider E. M., Dorries K., High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation. Transplantation Proceedings 1993 25 1 1271 1273 2-s2.0-0027478242 (Pubitemid 23078983)
100. Tan C. S., Dezube B. J., Bhargava P., Autissier P., Wüthrich C., Miller J., Koralnik I. J., Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. Journal of Infectious Diseases 2009 199 6 881 888 2-s2.0-65649083713 10.1086/597117
101. Marshall L. J., Dunham L., Major E. O., Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. Journal of General Virology 2010 91 12 3042 3052 2-s2.0-78650074421 10.1099/vir.0.023184-0
102. Messam C. A., Hou J., Gronostajski R. M., Major E. O., Lineage pathway of human brain progenitor cells identified by JC virus susceptability. Annals of Neurology 2003 53 5 636 646 2-s2.0-0038077562 10.1002/ana.10523 (Pubitemid 36529438)
103. Monaco M. C. G., Sabath B. F., Durham L. C., Major E. O., JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. Journal of Virology 2001 75 20 9687 9695 2-s2.0-0034812844 10.1128/JVI.75.20.9687-9695.2001 (Pubitemid 32900103)
104. Engelhardt B., Kappos L., Natalizumab: targeting α 4-integrins in multiple sclerosis. Neurodegenerative Diseases 2008 5 1 16 22 2-s2.0-37149030961 10.1159/000109933 (Pubitemid 350261811)
105. Jing D., Oelschlaegel U., Ordemann R., Hölig K., Ehninger G., Reichmann H., Ziemssen T., Bornhäuser M., CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function. Bone Marrow Transplantation 2010 45 10 1489 1496 2-s2.0-77957947043 10.1038/bmt.2009.381
106. Lindberg R. L. P., Achtnichts L., Hoffmann F., Kuhle J., Kappos L., Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. Journal of Neuroimmunology 2008 194 1-2 153 164 2-s2.0-39849089879 10.1016/j.jneuroim.2007.11.007
107. Reff M. E., Carner K., Chambers K. S., Chinn P. C., Leonard J. E., Raab R., Newman R. A., Hanna N., Anderson D. R., Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994 83 2 435 445 2-s2.0-0028057250 (Pubitemid 24030569)
108. McLaughlin P., Grillo-López A. J., Link B. K., Levy R., Czuczman M. S., Williams M. E., Heyman M. R., Bence-Bruckler I., White C. A., Cabanillas F., Jain V., Ho A. D., Lister J., Wey K., Shen D., Dallaire B. K., Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology 1998 16 8 2825 2833 2-s2.0-0345337254 (Pubitemid 28363048)
109. Lebwohl M., Tyring S. K., Hamilton T. K., Toth D., Glazer S., Tawfik N. H., Walicke P., Dummer W., Wang X., Garovoy M. R., Pariser D., A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. The New England Journal of Medicine 2003 349 21 2004 2013 2-s2.0-0345107256 10.1056/NEJMoa030002 (Pubitemid 37448923)
110. Guttman-Yassky E., Vugmeyster Y., Lowes M. A., Chamian F., Kikuchi T., Kagen M., Gilleaudeau P., Lee E., Hunte B., Howell K., Dummer W., Bodary S. C., Krueger J. G., Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness. Journal of Investigative Dermatology 2008 128 5 1182 1191 2-s2.0-42149156689 10.1038/jid.2008.4 (Pubitemid 351543222)
111. Knight D. M., Trinh H., Le J., Siegel S., Shealy D., McDonough M., Scallon B., Moor M. A., Vilcek J., Daddona P., Ghrayeb J., Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Molecular Immunology 1993 30 16 1443 1453 2-s2.0-0027361432 10.1016/0161-5890(93)90106-L
112. Van den Brande J. M. H., Braat H., Van den Brink G. R., Versteeg H. H., Bauer C. A., Hoedemaeker I., Van Montfrans C., Hommes D. W., Peppelenbosch M. P., Van Deventer S. J. H., Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003 124 7 1774 1785 2-s2.0-0038047689 10.1016/S0016-5085(03) 00382-2 (Pubitemid 36666774)
113. Van Den Brande J. M. H., Peppelenbosch M. P., Van Deventer S. J. H., Treating Crohn's disease by inducing T lymphocyte apoptosis. Annals of the New York Academy of Sciences 2002 973 166 180 2-s2.0-0036962407 (Pubitemid 36124999)
114. Domm S., Cinatl J., Mrowietz U., The impact of treatment with tumour necrosis factor- α antagonists on the course of chronic viral infections: a review of the literature. British Journal of Dermatology 2008 159 6 1217 1228 2-s2.0-56549129228 10.1111/j.1365-2133.2008.08851.x
115. Houff S. A., Berger J. R., The bone marrow, B cells, and JC virus. Journal of NeuroVirology 2008 14 5 341 343 2-s2.0-57049142007 10.1080/13550280802348222 (Pubitemid 352762873)
116. Du Pasquier R. A., Clark K. W., Smith P. S., Joseph J. T., Mazullo J. M., De Girolami U., Letvin N. L., Koralnik I. J., JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. Journal of NeuroVirology 2001 7 4 318 322 2-s2.0-0034834857 10.1080/13550280152537175 (Pubitemid 32894235)
117. Koralnik I. J., Du Pasquier R. A., Letvin N. L., JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. Journal of Virology 2001 75 7 3483 3487 2-s2.0-0035104810 10.1128/JVI.75.7.3483-3487.2001 (Pubitemid 32225913)
118. Lima M. A., Bernal-Cano F., Clifford D. B., Gandhi R. T., Koralnik I. J., Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. Journal of Neurology, Neurosurgery and Psychiatry 2010 81 11 1288 1291 2-s2.0-78649595709 10.1136/jnnp.2009.179002
119. Lima M. A., Marzocchetti A., Autissier P., Tompkins T., Chen Y., Gordon J., Clifford D. B., Gandhi R. T., Venna N., Berger J. R., Koralnik I. J., Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. Journal of Virology 2007 81 7 3361 3368 2-s2.0-33947364338 10.1128/JVI.01809-06 (Pubitemid 46456645)
120. Wüthrich C., Kesari S., Kim W. K., Williams K., Gelman R., Elmeric D., De Girolami U., Joseph J. T., Hedley-Whyte T., Koralnik I. J., Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8+T cells with JCV-infected glial cells. Journal of NeuroVirology 2006 12 2 116 128 2-s2.0-33746822397 10.1080/13550280600716604 (Pubitemid 44590938)
121. Matloubian M., Concepcion R. J., Ahmed R., CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. Journal of Virology 1994 68 12 8056 8063 2-s2.0-0027971622 (Pubitemid 24362694)
122. Chowdhury M., Kundu M., Khalili K., GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCV(L), in cells derived from central nervous system. Oncogene 1993 8 4 887 892 2-s2.0-0027537293 (Pubitemid 23087419)
123. Chowdhury M., Taylor J. P., Chang C. F., Rappaport J., Khalili K., Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. Journal of Virology 1992 66 12 7355 7361 2-s2.0-0026490852
124. Daniel D. C., Kinoshita Y., Khan M. A., Del Valle L., Khalili K., Rappaport J., Johnson E. M., Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA and Cell Biology 2004 23 12 858 867 2-s2.0-10344253813 10.1089/dna.2004.23.858 (Pubitemid 39628294)
125. Nukuzuma S., Nakamichi K., Kameoka M., Sugiura S., Nukuzuma C., Miyoshi I., Takegami T., Efficient propagation of progressive multifocal leukoencephalopathy-type JC virus in COS-7-derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1. Microbiology and Immunology 2010 54 12 758 762 2-s2.0-78649500451 10.1111/j.1348-0421.2010.00278.x
126. Remenick J., Radonovich M. F., Brady J. N., Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line. Journal of Virology 1991 65 10 5641 5646 2-s2.0-0026040852
127. Stettner M. R., Nance J. A., Wright C. A., Kinoshita Y., Kim W. K., Morgello S., Rappaport J., Khalili K., Gordon J., Johnson E. M., SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. Journal of General Virology 2009 90 8 2005 2014 2-s2.0-69449104035 10.1099/vir.0.011072-0
128. Tada H., Rappaport J., Lashgari M., Amini S., Wong-Staal F., Khalili K., Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proceedings of the National Academy of Sciences of the United States of America 1990 87 9 3479 3483 2-s2.0-0025368284 10.1073/pnas.87.9.3479 (Pubitemid 20173659)
129. Nukuzuma S., Kameoka M., Sugiura S., Nakamichi K., Nukuzuma C., Miyoshi I., Takegami T., Archetype JC virus efficiently propagates in kidney-derived cells stably expressing HIV-1 Tat. Microbiology and Immunology 2009 53 11 621 628 2-s2.0-75749118311 10.1111/j.1348-0421.2009.00166.x
130. Berger J. R., Chauhan A., Galey D., Nath A., Epidemiological evidence and molecular basis of interactions between HIV and JC virus. Journal of NeuroVirology 2001 7 4 329 338 2-s2.0-0034834036 10.1080/13550280152537193 (Pubitemid 32894237)
131. Churchill M. J., Wesselingh S. L., Cowley D., Pardo C. A., McArthur J. C., Brew B. J., Gorry P. R., Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Annals of Neurology 2009 66 2 253 258 2-s2.0-70149099556 10.1002/ana.21697
132. Li W., Li G., Steiner J., Nath A., Role of Tat protein in HIV neuropathogenesis. Neurotoxicity Research 2009 16 3 205 220 2-s2.0-70349900678 10.1007/s12640-009-9047-8
133. Masanetz S., Lehmann M. H., HIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxide. Virology Journal 2011 8, article 35 2-s2.0-78651576393 10.1186/1743-422X-8-35
134. Tornatore C., Meyers K., Atwood W., Conant K., Major E., Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. Journal of Virology 1994 68 1 93 102 2-s2.0-0028057831
135. Vincendeau M., Kramer S., Hadian K., Rothenaigner I., Bell J., Hauck S. M., Bickel C., Nagel D., Kremmer E., Werner T., Leib-Mösch C., Brack-Werner R., Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp). AIDS 2010 24 16 2433 2442 2-s2.0-78549250000 10.1097/QAD.0b013e32833e8758
136. Berger J. R., Progressive multifocal leukoencephalopathy and newer biological agents. Drug Safety 2010 33 11 969 983 2-s2.0-77957777247 10.2165/11537510-000000000-00000
137. Berger J. R., Kaszovitz B., Post M. J. D., Dickinson G., Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Annals of Internal Medicine 1987 107 1 78 87 2-s2.0-0023229323 (Pubitemid 17098643)
138. Tan C. S., Koralnik I. J., Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. The Lancet Neurology 2010 9 4 425 437 2-s2.0-77949297173 10.1016/S1474-4422(10) 70040-5
139. Moll N. M., Rietsch A. M., Ransohoff A. J., Cossoy M. B., Huang D., Eichler F. S., Trapp B. D., Ransohoff R. M., Cortical demyelination in PML and MS: similarities and differences. Neurology 2008 70 5 336 343 2-s2.0-39749200187 10.1212/01.wnl.0000284601.54436.e4 (Pubitemid 351653395)
140. Tallantyre E. C., Paine S. M. L., Sharp C. P., Lowe J. S., Gran B., Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutation. Archives of Neurology 2009 66 8 1021 1024 2-s2.0-68549090986 10.1001/archneurol.2009.94
141. Behzad-Behbahani A., Klapper P. E., Vallely P. J., Cleator G. M., Bonington A., BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis. Infection 2003 31 6 374 378 2-s2.0-0347477338 (Pubitemid 38005365)
142. Richardson E. P. Jr., Webster H. D., Progressive multifocal leukoencephalopathy: its pathological features. Progress in Clinical and Biological Research 1983 105 191 203 2-s2.0-0020689026
143. Du Pasquier R. A., Corey S., Margolin D. H., Williams K., Pfister L. A., De Girolami U., Mac Key J. J., Wüthrich C., Joseph J. T., Koralnik I. J., Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 2003 61 6 775 782 2-s2.0-10744220642 (Pubitemid 37174472)
144. Roux D., Bouldouyre M. A., Mercier-Delarue S., Seilhean D., Zagdanski A. M., Delaugerre C., Simon F., Molina J. M., Legoff J., JC virus variant associated with cerebellar atrophy in a patient with AIDS. Journal of Clinical Microbiology 2011 49 6 2196 2199 2-s2.0-79957496469 10.1128/JCM.02057-10
145. Shah R., Bag A. K., Chapman P. R., Curé J. K., Imaging manifestations of progressive multifocal leukoencephalopathy. Clinical Radiology 2010 65 6 431 439 2-s2.0-77951667069 10.1016/j.crad.2010.03.001
146. Whiteman M. L. H., Post M. J. D., Berger J. R., Tate L. G., Bell M. D., Limonte L. P., Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993 187 1 233 240 2-s2.0-0027401358 (Pubitemid 23097890)
147. Tavazzi E., White M. K., Khalili K., Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Reviews in Medical Virology 2012 22 1 18 32
148. Viscidi R. P., Khanna N., Tan C. S., JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clinical Infectious Diseases 2011 53 7 711 715
149. Ryschkewitsch C., Jensen P., Hou J., Fahle G., Fischer S., Major E. O., Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. Journal of Virological Methods 2004 121 2 217 221 2-s2.0-4644347753 10.1016/j.jviromet.2004.06.021 (Pubitemid 39295712)
150. Bossolasco S., Calori G., Moretti F., Boschini A., Bertelli D., Mena M., Gerevini S., Bestetti A., Pedale R., Sala S., Sala S., Lazzarin A., Cinque P., Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clinical Infectious Diseases 2005 40 5 738 744 2-s2.0-20144380567 10.1086/427698 (Pubitemid 40381351)
151. Marzocchetti A., Di Giambenedetto S., Cingolani A., Ammassari A., Cauda R., De Luca A., Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. Journal of Clinical Microbiology 2005 43 8 4175 4177 2-s2.0-23744496308 10.1128/JCM.43.8.4175-4177.2005 (Pubitemid 41129718)
152. Marzocchetti A., Sanguinetti M., Di Giambenedetto S., Cingolani A., Fadda G., Cauda R., De Luca A., Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis. Journal of NeuroVirology 2007 13 4 338 346 2-s2.0-34548652293 10.1080/13550280701381324 (Pubitemid 47400032)
153. Aksamit A. J., Sever J. L., Major E. O., Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry. Neurology 1986 36 4 499 504 2-s2.0-0022455988 (Pubitemid 16070003)
154. London W. T., Houff S. A., Madden D. L., Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 1978 201 4362 1246 1249 2-s2.0-0018131163 (Pubitemid 9029246)
155. London W. T., Houff S. A., McKeever P. E., Wallen W. C., Sever J. L., Padgett B. L., Walker D. L., Viral-induced astrocytomas in squirrel monkeys. Progress in Clinical and Biological Research 1983 105 227 237 2-s2.0-0020652661
156. Ohsumi S., Ikehara I., Motoi M., Induction of undifferentiated brain tumors in rats by a human polyomavirus (JC virus). Japanese Journal of Cancer Research 1985 76 6 429 431 2-s2.0-0022362793 (Pubitemid 15243600)
157. Del Valle L., White M. K., Khalili K., Potential mechanisms of the human polyomavirus JC in neural oncogenesis. Journal of Neuropathology and Experimental Neurology 2008 67 8 729 740 2-s2.0-52249093352 10.1097/NEN. 0b013e318180e631
158. Goudsmit J., Baak M. L., Slaterus K. W., Van Der Noordaa J., Human papovavirus isolated from urine of a child with acute tonsillitis. British Medical Journal 1981 283 6303 1363 1364 2-s2.0-0019813024 (Pubitemid 12228380)
159. Goudsmit J., Wertheim-van Dillen P., van Strien A., van der Noordaa J., The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. Journal of Medical Virology 1982 10 2 91 99 2-s2.0-0019985327 (Pubitemid 12030800)
160. Andrews C. A., Shah K. V., Daniel R. W., Hirsch M. S., Rubin R. H., A serological investigation of BK virus and JC virus infections in recipients of renal allografts. Journal of Infectious Diseases 1988 158 1 176 181 2-s2.0-0023682748
161. Bofill-Mas S., Formiga-Cruz M., Clemente-Casares P., Calafell F., Girones R., Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. Journal of Virology 2001 75 21 10290 10299 2-s2.0-0034795891 10.1128/JVI.75.21.10290-10299.2001 (Pubitemid 32948059)
162. Bofill-Mas S., Pina S., Girones R., Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Applied and Environmental Microbiology 2000 66 1 238 245 2-s2.0-0033987980 (Pubitemid 30030522)
163. Boldorini R., Allegrini S., Miglio U., Nestasio I., Paganotti A., Veggiani C., Monga G., Pietropaolo V., BK virus sequences in specimens from aborted fetuses. Journal of Medical Virology 2010 82 12 2127 2132 2-s2.0-78049365901 10.1002/jmv.21923
164. Boldorini R., Allegrini S., Miglio U., Paganotti A., Cocca N., Zaffaroni M., Riboni F., Monga G., Viscidi R., Serological evidence of vertical transmission of JC and BK Polyomaviruses in humans. Journal of General Virology 2011 92 5 1044 1050 2-s2.0-79955641958 10.1099/vir.0.028571-0
165. Brown D. W. G., Gardner S. D., Gibson P. E., Field A. M., BK virus specific IgM responses in cord sera, young children and healthy adults detected by RIA. Archives of Virology 1984 82 3-4 149 160 2-s2.0-0021747574 (Pubitemid 15184227)
166. Dolei A., Pietropaolo V., Gomes E., Di Taranto C., Ziccheddu M., Spanu M. A., Lavorino C., Manca M., Degener A. M., Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. Journal of General Virology 2000 81 8 1967 1973 2-s2.0-0033886502 (Pubitemid 30599177)
167. Pietropaolo V., Di Taranto C., Degener A. M., Transplacental transmission of human polyomavirus BK. Journal of Medical Virology 1998 56 4 372 376 (Pubitemid 28516607)
168. Zambrano A., Kalantari M., Simoneau A., Jensen J. L., Villarreal L. P., Detection of human polyomaviruses and papillomaviruses in prostatictissue reveals the prostate as a habitat for multipleviral infections. Prostate 2002 53 4 263 276 2-s2.0-0036892208 10.1002/pros.10157 (Pubitemid 35398497)
169. Jiang M., Abend J. R., Johnson S. F., Imperiale M. J., The role of polyomaviruses in human disease. Virology 2009 384 2 266 273 2-s2.0-59349105146 10.1016/j.virol.2008.09.027
170. Yogo Y., Sugimoto C., Zhong S., Homma Y., Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications. Reviews in Medical Virology 2009 19 4 185 199 2-s2.0-67650898292 10.1002/rmv.613
171. Jin L., Gibson P. E., Booth J. C., Clewley J. P., Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. Journal of Medical Virology 1993 41 1 11 17 2-s2.0-0027184598 (Pubitemid 23267496)
172. Jin L., Gibson P. E., Knowles W. A., Clewley J. P., BK virus antigenic variants: sequence analysis within the capsid VP1 epitope. Journal of Medical Virology 1993 39 1 50 56 2-s2.0-0027393759 10.1002/jmv.1890390110 (Pubitemid 23030416)
173. Ikegaya H., Saukko P. J., Tertti R., Metsärinne K. P., Carr M. J., Crowley B., Sakurada K., Zheng H. Y., Kitamura T., Yogo Y., Identification of a genomic subgroup of BK polyomavirus spread in European populations. Journal of General Virology 2006 87 11 3201 3208 2-s2.0-33750276374 10.1099/vir.0.82266-0 (Pubitemid 44608355)
174. Zheng H. Y., Nishimoto Y., Chen Q., Hasegawa M., Zhong S., Ikegaya H., Ohno N., Sugimoto C., Takasaka T., Kitamura T., Yogo Y., Relationships between BK virus lineages and human populations. Microbes and Infection 2007 9 2 204 213 2-s2.0-33846857961 10.1016/j.micinf.2006.11.008 (Pubitemid 46228003)
175. Chen Q., Zheng H. Y., Zhong S., Subtype IV of the BK polyomavirus is prevalent in East Asia. Archives of Virology 2006 151 12 2419 2429 (Pubitemid 44819338)
176. Carr M. J., McCormack G. P., Mutton K. J., Crowley B., Unique BK virus non-coding control region (NCCR) variants in hematopoietic stem cell transplant recepients with and without hemorrhagic cystitis. Journal of Medical Virology 2006 78 4 485 493 2-s2.0-33644755935 10.1002/jmv.20566 (Pubitemid 43346900)
177. Di Taranto C., Pietropaolo V., Orsi G. B., Jin L., Sinibaldi L., Degener A. M., Detection of BK polyomavirus genotypes in healthy and HIV-positive children. European Journal of Epidemiology 1997 13 6 653 657 2-s2.0-0030870701 10.1023/A:1007371320999 (Pubitemid 27375069)
178. Jin L., Pietropaolo V., Booth J. C., Ward K. H., Brown D. W., Prevalence and distribution of BK virus subtypes in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis. Clinical and Diagnostic Virology 1995 3 3 285 295 2-s2.0-0028903177 10.1016/S0928-0197(94)00044-1
179. Krumbholz A., Zell R., Egerer R., Sauerbrei A., Helming A., Gruhn B., Wutzler P., Prevalence of BK virus subtype I in Germany. Journal of Medical Virology 2006 78 12 1588 1598 2-s2.0-33750562751 10.1002/jmv.20743 (Pubitemid 44672502)
180. Nishimoto Y., Takasaka T., Hasegawa M., Zheng H. Y., Chen Q., Sugimoto C., Kitamura T., Yogo Y., Evolution of BK virus based on complete genome data. Journal of Molecular Evolution 2006 63 3 341 352 2-s2.0-33745607996 10.1007/s00239-005-0092-5 (Pubitemid 44440476)
181. Yogo Y., Zhong S., Suzuki M., Shibuya A., Kitamura T., Occurrence of the European subgroup of subtype I BK polyomavirus in Japanese-Americans suggests transmission outside the family. Journal of Virology 2007 81 23 13254 13258 2-s2.0-36348936220 10.1128/JVI.01018-07 (Pubitemid 350156964)
182. Wiseman A. C., Polyomavirus nephropathy: a current perspective and clinical considerations. American Journal of Kidney Diseases 2009 54 1 131 142 2-s2.0-67449143210 10.1053/j.ajkd.2009.01.271
183. Egli A., Infanti L., Dumoulin A., Buser A., Samaridis J., Stebler C., Gosert R., Hirsch H. H., Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. Journal of Infectious Diseases 2009 199 6 837 846 2-s2.0-65649099693 10.1086/597126
184. O'Donnell P. H., Swanson K., Josephson M. A., Artz A. S., Parsad S. D., Ramaprasad C., Pursell K., Rich E., Stock W., van Besien K., BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. Biology of Blood and Marrow Transplantation 2009 15 9 1038.e1 1048.e1 2-s2.0-67849088512 10.1016/j.bbmt.2009.04.016
185. Wong A. S. Y., Chan K. H., Cheng V. C. C., Yuen K. Y., Kwong Y. L., Leung A. Y. H., Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clinical Infectious Diseases 2007 44 6 830 837 2-s2.0-33847638925 10.1086/511863 (Pubitemid 46365309)
186. Bogdanovic G., Priftakis P., Giraud G., Kuzniar M., Ferraldeschi R., Kokhaei P., Mellstedt H., Remberger M., Ljungman P., Winiarski J., Dalianis T., Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. Journal of Clinical Microbiology 2004 42 11 5394 5396 2-s2.0-8644230860 10.1128/JCM.42.11.5394-5396.2004 (Pubitemid 39506267)
187. Cesaro S., Facchin C., Tridello G., Messina C., Calore E., Biasolo M. A., Pillon M., Varotto S., Brugiolo A., Mengoli C., Palù G., A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation 2008 41 4 363 370 2-s2.0-40249090121 10.1038/sj.bmt.1705909 (Pubitemid 351330731)
188. Tanaka K., Hori T., Hatakeyama N., Yamamoto M., Takayama R., Yoto Y., Suzuki N., Hayashi T., Ikeda Y., Ikeda H., Ishida T., Tsutsumi H., Quantification of BK polyoma viruria in Japanese children and adults with hemorrhagic cystitis complicating stem cell transplantation. Journal of Medical Virology 2008 80 12 2108 2112 2-s2.0-57349140374 10.1002/jmv.21328
189. Erard V., Kim H. W., Corey L., Limaye A., Huang M. L., Myerson D., Davis C., Boeckh M., BK DNA viral load in plasma: Evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005 106 3 1130 1132 2-s2.0-23044455335 10.1182/blood-2004-12-4988 (Pubitemid 41076464)
190. Saundh B. K., Baker R., Harris M., Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy. Journal of Infectious Diseases 2013 207 1 137 141
191. van Aalderen M. C., Heutinck K. M., Huisman C., BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response. Netherlands Journal of Medicine 2012 70 4 172 183
192. Kuypers D. R., Management of polyomavirus-associated nephropathy in renal transplant recipients. Nature Reviews Nephrology 2012 8 7 390 402
193. Boothpur R., Brennan D. C., Human polyoma viruses and disease with emphasis on clinical BK and JC. Journal of Clinical Virology 2010 47 4 306 312 2-s2.0-77949484768 10.1016/j.jcv.2009.12.006
194. Nickeleit V., Hirsch H. H., Binet I. F., Gudat F., Prince O., Dalquen P., Thiel G., Mihatsch M. J., Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. Journal of the American Society of Nephrology 1999 10 5 1080 1089 2-s2.0-0032960686 (Pubitemid 29203096)
195. Mengel M., Marwedel M., Radermacher J., Eden G., Schwarz A., Haller H., Kreipe H., Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrology Dialysis Transplantation 2003 18 6 1190 1196 2-s2.0-0038684561 10.1093/ndt/gfg072 (Pubitemid 36722523)
196. Comoli P., Azzi A., Maccario R., Basso S., Botti G., Basile G., Fontana I., Labirio M., Cometa A., Poli F., Perfumo F., Locatelli F., Ginevri F., Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004 78 8 1229 1232 2-s2.0-7044260431 10.1097/01.TP.0000137932.44791.D3 (Pubitemid 39426446)
197. Comoli P., Binggeli S., Ginevri F., Hirsch H. H., Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transplant Infectious Disease 2006 8 2 86 94 2-s2.0-33744787354 10.1111/j.1399-3062.2006.00167.x (Pubitemid 43829485)
198. Abend J. R., Low J. A., Imperiale M. J., Inhibitory effect of gamma interferon on BK virus gene expression and replication. Journal of Virology 2007 81 1 272 279 2-s2.0-33845750574 10.1128/JVI.01571-06 (Pubitemid 44975167)
199. Hirsch H. H., Knowles W., Dickenmann M., Passweg J., Klimkait T., Mihatsch M. J., Steiger J., Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. The New England Journal of Medicine 2002 347 7 488 496 2-s2.0-0037103426 10.1056/NEJMoa020439 (Pubitemid 34879336)
200. Bohl D. L., Storch G. A., Ryschkewitsch C., Gaudreault-Keener M., Schnitzler M. A., Major E. O., Brennan D. C., Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. American Journal of Transplantation 2005 5 9 2213 2221 2-s2.0-27844445732 10.1111/j.1600-6143.2005.01000.x (Pubitemid 41648468)
201. Luo C., Hirsch H. H., Kant J., VP-1 quasispecies in human infection with polyomavirus BK. Journal of Medical Virology 2012 84 1 152 161
202. Olsen G. H., Hirsch H. H., Rinaldo C. H., Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients. Journal of Medical Virology 2009 81 11 1959 1967 2-s2.0-70350469060 10.1002/jmv.21605
203. Sood P., Senanayake S., Sujeet K., Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study. Transplantation 2012 93 3 291 296
204. Thomas D. L., Thio C. L., Martin M. P., Qi Y., Ge D., Ohuigin C., Kidd J., Kidd K., Khakoo S. I., Alexander G., Goedert J. J., Kirk G. D., Donfield S. M., Rosen H. R., Tobler L. H., Busch M. P., McHutchison J. G., Goldstein D. B., Carrington M., Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009 461 7265 798 801 2-s2.0-70349966196 10.1038/nature08463
205. Geddes C. C., Gunson R., Mazonakis E., Wan R., Thomson L., Clancy M., Carman W. F., BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen. Transplant Infectious Disease 2011 13 2 109 116 2-s2.0-79953318993 10.1111/j.1399-3062.2010.00566.x
206. Khan H., Oberoi S., Mahvash A., Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement. Biology of Blood and Marrow Transplantation 2011 17 10 1551 1555
207. Hirsch H. H., Mohaupt M., Klimkait T., Limaye A. P., Jerome K. R., Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. Journal of Infectious Diseases 2001 184 11 1494 1496 2-s2.0-0035577457 10.1086/324425 (Pubitemid 33108869)
208. Viscount H. B., Eid A. J., Espy M. J., Griffin M. D., Thomsen K. M., Harmsen W. S., Razonable R. R., Smith T. F., Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 2007 84 3 340 345 2-s2.0-34547887997 10.1097/01.tp.0000275205. 41078.51 (Pubitemid 47258321)
209. Smith F., Panek R., Kiberd B. A., Screening to prevent polyoma virus nephropathy in kidney transplantation: a cost analysis: brief communication. American Journal of Transplantation 2009 9 9 2177 2179 2-s2.0-69149086366 10.1111/j.1600-6143.2009.02729.x
210. Pastrana D. V., Brennan D. C., Cuburu N., Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLOS Pathogens 2012 8 4 e1002650
211. Randhawa P. S., Khaleel-Ur-Rehman K., Swalsky P. A., Vats A., Scantlebury V., Shapiro R., Finkelstein S., DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002 73 7 1090 1094 2-s2.0-0037090902 (Pubitemid 34415440)
212. Abend J. R., Jiang M., Imperiale M. J., BK virus and human cancer: innocent until proven guilty. Seminars in Cancer Biology 2009 19 4 252 260 2-s2.0-67349205142 10.1016/j.semcancer.2009.02.004
213. Arora R., Chang Y., Moore P. S., MCV and Merkel cell carcinoma: a molecular success story. Current Opinion in Virology 2012 2 4 489 498
214. Spurgeon M. E., Lambert P. F., Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology 2013 435 1 118 130
215. Nicol J. T., Robinot R., Carpentier A., Age-specific seroprevalence of Merkel cell polyomavirus, human polyomaviruses 6, 7 and 9 and Trichodysplasia Spinulosa-associated polyomavirus. Clinical and Vaccine Immunology 2013 20 3 363 368
216. Tolstov Y. L., Pastrana D. V., Feng H., Becker J. C., Jenkins F. J., Moschos S., Chang Y., Buck C. B., Moore P. S., Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. International Journal of Cancer 2009 125 6 1250 1256 2-s2.0-68249144369 10.1002/ijc.24509
217. Tolstov Y. L., Knauer A., Chen J. G., Kensler T. W., Kingsley L. A., Moore P. S., Chang Y., Asymptomatic primary merkel cell polyomavirus infection among adults. Emerging Infectious Diseases 2011 17 8 1371 1380 2-s2.0-79960875663 10.3201/eid1708.110079
218. Heath M., Jaimes N., Lemos B., Mostaghimi A., Wang L. C., Peñas P. F., Nghiem P., Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. Journal of the American Academy of Dermatology 2008 58 3 375 381 2-s2.0-38949125129 10.1016/j.jaad.2007.11.020 (Pubitemid 351226308)
219. Engels E. A., Frisch M., Goedert J. J., Biggar R. J., Miller R. W., Merkel cell carcinoma and HIV infection. The Lancet 2002 359 9305 497 498 2-s2.0-0037045561 10.1016/S0140-6736(02)07668-7 (Pubitemid 34164301)
220. Agelli M., Clegg L. X., Becker J. C., The etiology and epidemiology of merkel cell carcinoma. Current Problems in Cancer 2010 34 1 14 37
221. Muirhead R., Ritchie D. M., Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. Clinical Oncology 2007 19 1 96 2-s2.0-33845981478 10.1016/j.clon.2006.10.001 (Pubitemid 46044067)
222. Gianfreda M., Caiffi S., De Franceschi T., Dodero C., Durante R., Faletti P., Rebuttato A., Schivo A., Tassara R., Merkel cell carcinoma of the skin in a patient with Myasthenia gravis. Minerva Medica 2002 3 219 222 2-s2.0-0035983671 (Pubitemid 34875539)
223. McLoone N. M., McKenna K., Edgar D., Walsh M., Bingham A., Merkel cell carcinoma in a patient with chronic sarcoidosis. Clinical and Experimental Dermatology 2005 30 5 580 582 2-s2.0-23044516605 10.1111/j.1365-2230.2005.01800. x (Pubitemid 41076034)
224. Nemoto I., Sato-Matsumura K. C., Fujita Y., Natsuga K., Ujiie H., Tomita Y., Kato N., Kondo M., Ohnishi K., Leukaemic dissemination of Merkel cell carcinoma in a patient with systemic lupus erythematosus. Clinical and Experimental Dermatology 2008 33 3 270 272 2-s2.0-42249113677 10.1111/j.1365-2230.2007.02618.x (Pubitemid 351550622)
225. Satolli F., Venturi C., Vescovi V., Morrone P., De Panfilis G., Merkel-cell carcinoma in Behçet's disease. Acta Dermato-Venereologica 2005 85 1 79 2-s2.0-19744383569 10.1080/00015550410021664 (Pubitemid 40254692)
226. Casimir G. J. A., Duchateau J., Gender differences in inflammatory processes could explain poorer prognosis for males. Journal of Clinical Microbiology 2011 49 1 478 479 2-s2.0-78650881913 10.1128/JCM.02096-10
227. Pastrana D. V., Tolstov Y. L., Becker J. C., Moore P. S., Chang Y., Buck C. B., Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathogens 2009 5 9 2-s2.0-70349693465 10.1371/journal.ppat.1000578 e1000578
228. Wooff J. C., Trites J. R., Walsh N. M. G., Bullock M. J., Complete spontaneous regression of metastatic merkel cell carcinoma: a case report and review of the literature. American Journal of Dermatopathology 2010 32 6 614 617 2-s2.0-77955176222 10.1097/DAD.0b013e3181cd3158
229. Shuda M., Feng H., Kwun H. J., Rosen S. T., Gjoerup O., Moore P. S., Chang Y., T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proceedings of the National Academy of Sciences of the United States of America 2008 105 42 16272 16277 2-s2.0-55849098118 10.1073/pnas.0806526105
230. Arora R., Shuda M., Guastafierro A., Survivin is a therapeutic target in Merkel cell carcinoma. Science Translational Medicine 2012 4 133 133ra56
231. Allander T., Tammi M. T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B., Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proceedings of the National Academy of Sciences of the United States of America 2005 102 36 12891 12896 2-s2.0-24644516529 10.1073/pnas.0504666102 (Pubitemid 41279460)
232. Abedi Kiasari B., Vallely P. J., Corless C. E., Al-Hammadi M., Klapper P. E., Age-related pattern of KI and WU polyomavirus infection. Journal of Clinical Virology 2008 43 1 123 125 2-s2.0-49749114330 10.1016/j.jcv.2008.05.003
233. Babakir-Mina M., Ciccozzi M., Dimonte S., Farchi F., Valdarchi C., Rezza G., Perno C. F., Ciotti M., Identification of the novel KI polyomavirus in the respiratory tract of an Italian patient. Journal of Medical Virology 2008 80 11 2012 2014 2-s2.0-53249138236 10.1002/jmv.21303
234. Bialasiewicz S., Whiley D. M., Lambert S. B., Jacob K., Bletchly C., Wang D., Nissen M. D., Sloots T. P., Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection. Journal of Clinical Virology 2008 41 2 63 68 2-s2.0-38749134112 10.1016/j.jcv.2007.11.001
235. Foulongne V., Brieu N., Jeziorski E., Chatain A., Rodière M., Segondy M., KI and WU polyomaviruses in children, France. Emerging Infectious Diseases 2008 14 3 523 525 2-s2.0-41349089325 (Pubitemid 351451418)
236. Norja P., Ubillos I., Templeton K., Simmonds P., No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. Journal of Clinical Virology 2007 40 4 307 311 2-s2.0-36348933323 10.1016/j.jcv.2007.09.008 (Pubitemid 350152006)
237. Payungporn S., Chieochansin T., Thongmee C., Samransamruajkit R., Theamboolers A., Poovorawan Y., Prevalence and molecular characterization of WU/KI polyomaviruses isolated from pediatric patients with respiratory disease in Thailand. Virus Research 2008 135 2 230 236 2-s2.0-46149086547 10.1016/j.virusres.2008.03.018
238. van de Pol A. C., Wolfs T. F. W., Jansen N. J. G., Kimpen J. L. L., Van Loon A. M., Rossen J. W. A., Human bocavirus and KI/WU polyomaviruses in pediatric intensive care patients. Emerging Infectious Diseases 2009 15 3 454 457 2-s2.0-63849329315 10.3201/eid1503.081203
239. Mourez T., Bergeron A., Ribaud P., Scieux C., De Latour R. P., Tazi A., Socié G., Simon F., LeGoff J., Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerging Infectious Diseases 2009 15 1 107 109 2-s2.0-58849102278 10.3201/1501.080758
240. Babakir-Mina M., Ciccozzi M., Farchi F., Bergallo M., Cavallo R., Adorno G., Perno C. F., Ciotti M., KI and WU polyomaviruses and CD4+ cell counts in HIV-1-infected patients, Italy. Emerging Infectious Diseases 2010 16 9 1482 1485 2-s2.0-77956037283 10.3201/eid1609.100211
241. Babakir-Mina M., Ciccozzi M., Alteri C., Polchi P., Picardi A., Greco F., Lucarelli G., Arcese W., Perno C. F., Ciotti M., Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. Journal of Medical Virology 2009 81 9 1668 1673 2-s2.0-68049096755 10.1002/jmv.21559
242. Barzon L., Squarzon L., Militello V., Trevisan M., Porzionato A., Macchi V., De Caro R., Palù G., WU and KI polyomaviruses in the brains of hiv-positive patients with and without progressive multifocal leukoencephalopathy. Journal of Infectious Diseases 2009 200 11 1755 1758 2-s2.0-72849138513 10.1086/648095
243. Babakir-Mina M., Ciccozzi M., Perno C. F., The novel KI, WU, MC polyomaviruses: possible human pathogens? New Microbiologica 2011 34 1 1 8
244. Kuypers J., Campbell A. P., Guthrie K. A., WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipients. Emerging Infectious Diseases 2012 18 10 1580 1588
245. Abed Y., Wang D., Boivin G., WU polyomavirus in children, Canada. Emerging Infectious Diseases 2007 13 12 1939 1941 2-s2.0-37049010160 (Pubitemid 350248504)
246. Tae H. H., Chung J. Y., Ja W. K., Sang W. K., Hwang E. S., WU polyomavirus in children with acute lower respiratory tract infections, South Korea. Emerging Infectious Diseases 2007 13 11 1766 1768 2-s2.0-36249032650 (Pubitemid 350126210)
247. Le B. M., Demertzis L. M., Wu G., Tibbets R. J., Buller R., Arens M. Q., Gaynor A. M., Storch G. A., Wang D., Clinical and epidemiologic characterization of WU polyomavirus infection, St. Louis, Missouri. Emerging Infectious Diseases 2007 13 12 1936 1938 2-s2.0-37049034308 (Pubitemid 350248503)
248. Lin F., Zheng M., Li H., Zheng C., Li X., Rao G., Zheng M., Wu F., Zeng A., WU polyomavirus in children with acute lower respiratory tract infections, China. Journal of Clinical Virology 2008 42 1 94 102 2-s2.0-42649136221 10.1016/j.jcv.2007.12.009
249. Neske F., Blessing K., Ullrich F., Pröttel A., Kreth H. W., Weissbrich B., WU polyomavirus infection in children, Germany. Emerging Infectious Diseases 2008 14 4 680 681 2-s2.0-42049107540 (Pubitemid 351520882)
250. Barzon L., Squarzon L., Pacenti M., Scotton P. G., Palú G., Detection of WU polyomavirus in cerebrospinal fluid specimen from a patient with AIDS and suspected progressive multifocal leukoencephalopathy. Journal of Infectious Diseases 2009 200 2 314 315 2-s2.0-67650677092 10.1086/599842
251. Siebrasse E. A., Bauer I., Holtz L. R., Human polyomaviruses in children undergoing transplantation, United States, 2008-2010. Emerging Infectious Diseases 2012 18 10 1676 1679
252. Brimhall C. L., Malone J. C., Viral-associated trichodysplasia spinulosa in a renal transplant patient. Archives of Dermatology 2012 148 7 863 864
253. Chastain M. A., Millikan L. E., Pilomatrix dysplasia in an immunosuppressed patient. Journal of the American Academy of Dermatology 2000 43 1 118 122 2-s2.0-0034235936 (Pubitemid 30439724)
254. Haycox C. L., Kim S., Fleckman P., Smith L. T., Piepkorn M., Sundberg J. P., Howell D. N., Miller S. E., Trichodysplasia spinulosa-a newly described folliculocentric viral infection in an immunocompromised host. Journal of Investigative Dermatology Symposium Proceedings 1999 4 3 268 271 2-s2.0-0033397241 (Pubitemid 30085818)
255. Heaphy M. R. Jr., Shamma H. N., Hickmann M., White M. J., Cyclosporine-induced folliculodystrophy. Journal of the American Academy of Dermatology 2004 50 2 310 315 2-s2.0-0842332454 10.1016/S0190-9622(03)00774-6 (Pubitemid 38174297)
256. Lee J. S. S., Frederiksen P., Kossard S., Progressive trichodysplasia spinulosa in a patient with chronic lymphocytic leukaemia in remission. Australasian Journal of Dermatology 2008 49 1 57 60 2-s2.0-37849004405 10.1111/j.1440-0960.2007.00422.x
257. Matthews M. R., Wang R. C., Reddick R. L., Saldivar V. A., Browning J. C., Viral-associated trichodysplasia spinulosa: a case with electron microscopic and molecular detection of the trichodysplasia spinulosa-associated human polyomavirus. Journal of Cutaneous Pathology 2011 38 5 420 431 2-s2.0-79953309060 10.1111/j.1600-0560.2010.01664.x
258. Osswald S. S., Kulick K. B., Tomaszewski M. M., Sperling L. C., Viral-associated trichodysplasia in a patient with lymphoma: a case report and review. Journal of Cutaneous Pathology 2007 34 9 721 725 2-s2.0-34547865352 10.1111/j.1600-0560.2006.00693.x (Pubitemid 47256249)
259. Sadler G. M., Halbert A. R., Smith N., Rogers M., Trichodysplasia spinulosa associated with chemotherapy for acute lymphocytic leukaemia. Australasian Journal of Dermatology 2007 48 2 110 114 2-s2.0-34249096124 10.1111/j.1440-0960.2007.00348.x (Pubitemid 46802052)
260. Schwieger-Briel A., Balma-Mena A., Ngan B., Dipchand A., Pope E., Trichodysplasia spinulosa-a rare complication in immunosuppressed patients. Pediatric Dermatology 2010 27 5 509 513 2-s2.0-77957297165 10.1111/j.1525-1470. 2010.01278.x
261. Sperling L. C., Tomaszewski M. M., Thomas D. A., Viral-associated trichodysplasia in patients who are immunocompromised. Journal of the American Academy of Dermatology 2004 50 2 318 322 2-s2.0-0842289302 10.1016/S0190- 9622(03)01490-7 (Pubitemid 38174299)
262. Wyatt A. J., Sachs D. L., Shia J., Delgado R., Busam K. J., Virus-associated trichodysplasia spinulosa. American Journal of Surgical Pathology 2005 29 2 241 246 2-s2.0-12844263472 10.1097/01.pas.0000149691.83086. dc (Pubitemid 40170643)
263. Kazem S., van der Meijden E., Kooijman S., Trichodysplasia spinulosa is characterized by active polyomavirus infection. Journal of Clinical Virology 2012 53 3 225 230
264. van der Meijden E., Kazem S., Burgers M. M., Janssens R., Bavinck J. N. B., de Melker H., Feltkamp M. C., Seroprevalence of trichodysplasia spinulosa-associated polyomavirus. Emerging Infectious Diseases 2011 17 8 1355 1363 2-s2.0-79960865379 10.3201/eid1708.110114
265. Chen T., Mattila P. S., Jartti T., Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. Journal of Infectious Diseases 2011 204 10 1523 1526
266. Sadeghi M., Aronen M., Chen T., Merkel cell polyomavirus and trichodysplasia spinulosa-associated polyomavirus DNAs and antibodies in blood among the elderly. BMC Infectious Diseases 2012 12, article 383
267. Leendertz F. H., Scuda N., Cameron K. N., Kidega T., Zuberbühler K., Leendertz S. A. J., Couacy-Hymann E., Boesch C., Calvignac S., Ehlers B., African great apes are naturally infected with polyomaviruses closely related to Merkel cell polyomavirus. Journal of Virology 2011 85 2 916 924 2-s2.0-78650672089 10.1128/JVI.01585-10
268. Takemoto K. K., Furuno A., Kato K., Yoshike K., Biological and biochemical studies of African green monkey lymphotropic papovavirus. Journal of Virology 1982 42 2 502 509 2-s2.0-0020034354 (Pubitemid 12113060)
269. Nicol J. T., Touze A., Robinot R., Seroprevalence and cross-reactivity of human polyomavirus 9. Emerging Infectious Diseases 2012 18 8 1329 1332
270. Trusch F., Klein M., Finsterbusch T., Seroprevalence of human polyomavirus 9 and cross-reactivity to African green monkey-derived lymphotropic polyomavirus. Journal of General Virology 2012 934, part 4 698 705
271. Csoma E., Sapy T., Meszaros B., Novel human polyomaviruses in pregnancy: higher prevalence of BKPyV, but no WUPyV, KIPyV and HPyV9. Journal of Clinical Virology 2012 55 3 262 265
272. Imajoh M., Hashida Y., Taniguchi A., Novel human polyomaviruses, Merkel cell polyomavirus and human polyomavirus 9, in Japanese chronic lymphocytic leukemia cases. Journal of Hematology & Oncology 2012 5, article 25
273. Yu G., Greninger A. L., Isa P., Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One 2012 7 11 e49449
274. Bauman Y., Mandelboim O., MicroRNA based immunoevasion mechanism of human polyomaviruses. RNA Biology 2011 8 4 591 594 2-s2.0-79960097718
275. Boss I. W., Renne R., Viral miRNAs and immune evasion. Biochimica et Biophysica Acta 2011 1809 11-12 708 714
276. Sullivan C. S., Grundhoff A. T., Tevethia S., Pipas J. M., Ganem D., SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005 435 7042 682 686 2-s2.0-20444446357 10.1038/nature03576 (Pubitemid 40825513)
277. Seo G. J., Fink L. H. L., O'Hara B., Atwood W. J., Sullivan C. S., Evolutionarily conserved function of a viral microRNA. Journal of Virology 2008 82 20 9823 9828 2-s2.0-53749099136 10.1128/JVI.01144-08
278. Osman A., MicroRNAs in health and disease-basic science and clinical applications. Clinical Laboratory 2012 58 5-6 393 402
279. Bauman Y., Nachmani D., Vitenshtein A., Tsukerman P., Drayman N., Stern-Ginossar N., Lankry D., Gruda R., Mandelboim O., An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host and Microbe 2011 9 2 93 102 2-s2.0-79951603090 10.1016/j.chom.2011.01.008
280. Lee S., Paulson K. G., Murchison E. P., Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas. Journal of Clinical Virology 2011 52 3 272 275
281. Seo G. J., Chen C. J., Sullivan C. S., Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology 2009 383 2 183 187 2-s2.0-58149112225 10.1016/j.virol.2008.11.001
282. Kuypers D. R. J., Bammens B., Claes K., Evenepoel P., Lerut E., Vanrenterghem Y., A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. Journal of Antimicrobial Chemotherapy 2009 63 2 417 419 2-s2.0-58849116368 10.1093/jac/dkn495
283. Safrin S., Cherrington J., Jaffe H. S., Clinical uses of cidofovir. Reviews in Medical Virology 1997 7 3 145 156 (Pubitemid 27386625)
284. Gosert R., Rinaldo C. H., Wernli M., Major E. O., Hirsch H. H., CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus jc replication in human brain progenitor-derived astrocytes. Antimicrobial Agents and Chemotherapy 2011 55 5 2129 2136 2-s2.0-79955549826 10.1128/AAC.00046-11
285. Jiang Z. G., Cohen J., Marshall L. J., Major E. O., Hexadecyloxypropyl- cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures. Antimicrobial Agents and Chemotherapy 2010 54 11 4723 4732 2-s2.0-78049256334 10.1128/AAC.00837-10
286. Patel A., Patel J., Ikwuagwu J., A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. Journal of Antimicrobial Chemotherapy 2010 65 12 2697 2698 2-s2.0-78149487237 10.1093/jac/dkq359
287. Painter W., Robertson A., Trost L. C., First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. Antimicrobial Agents and Chemotherapy 2012 56 5 2726 2734
288. Rinaldo C. H., Gosert R., Bernhoff E., Finstad S., Hirsch H. H., 1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells. Antimicrobial Agents and Chemotherapy 2010 54 11 4714 4722 2-s2.0-78049268991 10.1128/AAC.00974-10
289. Wanat K. A., Holler P. D., Dentchev T., Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights. Archives of Dermatology 2012 148 2 219 223
290. Aksamit A. J., Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. Journal of NeuroVirology 2001 7 4 386 390 2-s2.0-0034827241 10.1080/13550280152537292 (Pubitemid 32894247)
291. Marra C. M., Rajicic N., Barker D. E., Cohen B. A., Clifford D., Donovan Post M. J., Ruiz A., Bowen B. C., Huang M. L., Queen-Baker J., Andersen J., Kelly S., Shriver S., A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 2002 16 13 1791 1797 2-s2.0-18644377201 10.1097/00002030-200209060-00012
292. Hou J., Major E. O., The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. Journal of NeuroVirology 1998 4 4 451 456 2-s2.0-0031855486 (Pubitemid 28395727)
293. Razonable R. R., Aksamit A. J., Wright A. J., Wilson J. W., Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clinic Proceedings 2001 76 11 1171 1175 2-s2.0-0034759956 (Pubitemid 33032394)
294. Savona M. R., Newton D., Frame D., Levine J. E., Mineishi S., Kaul D. R., Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplantation 2007 39 12 783 787 2-s2.0-34250219674 10.1038/sj.bmt.1705678 (Pubitemid 46901977)
295. Yagi T., Hattori H., Ohira M., Nakamichi K., Takayama-Ito M., Saijo M., Shimizu T., Ito D., Takahashi K., Suzuki N., Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. Clinical Neurology and Neurosurgery 2010 112 2 153 156 2-s2.0-74149084951 10.1016/j.clineuro.2009.10.005
296. Berenguer J., Miralles P., Arrizabalaga J., Ribera E., Dronda F., Baraia-Etxaburu J., Domingo P., Márquez M., Rodriguez-Arrondo F. J., Laguna F., Rubio R., Rodrigo J. L., Mallolas J., De Miguel V., Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clinical Infectious Diseases 2003 36 8 1047 1052 2-s2.0-0037445554 10.1086/374048 (Pubitemid 36513291)
297. De Luca A., Ammassari A., Pezzotti P., Cinque P., Gasnault J., Berenguer J., Di Giambenedetto S., Cingolani A., Taoufik Y., Miralles P., Marra C. M., Antinori A., Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 2008 22 14 1759 1767 2-s2.0-66149113825 10.1097/QAD. 0b013e32830a5043
298. Portegies P., Algra P. R., Hollak C. E. M., Prins J. M., Reiss P., Valk J., Lange J. M. A., Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. The Lancet 1991 337 8742 680 681 2-s2.0-0026029596 10.1016/0140-6736(91)92504-U
299. Vulliemoz S., Lurati-Ruiz F., Borruat F. X., Delavelle J., Koralnik I. J., Kuntzer T., Bogousslavsky J., Picard F., Landis T., Du Pasquier R. A., Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. Journal of Neurology, Neurosurgery and Psychiatry 2006 77 9 1079 1082 2-s2.0-33747390801 10.1136/jnnp.2006.092353 (Pubitemid 44338537)
300. Antinori A., De Luca A., Ammassari A., Cingolani A., Murri B., Colosimo G., Roselli R., Scerrati M., Tamburrini E., Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy. AIDS 1994 8 7 1022 1024 2-s2.0-0028321489 (Pubitemid 24206623)
301. Tubridy N., Wells C., Lewis D., Schon F., Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis. Journal of the Royal Society of Medicine 2000 93 7 374 375 2-s2.0-0033925775 (Pubitemid 30461814)
302. Hall C. D., Dafni U., Simpson D., Clifford D., Wetherill P. E., Cohen B., Mcarthur J., Hollander H., Yainnoutsos C., Major E., Millar L., Timpone J., Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. The New England Journal of Medicine 1998 338 19 1345 1351 2-s2.0-0344743110 10.1056/NEJM199805073381903 (Pubitemid 28216663)
303. Elphick G. F., Querbes W., Jordan J. A., Gee G. V., Eash S., Manley K., Dugan A., Stanifer M., Bhatnagar A., Kroeze W. K., Roth B. L., Atwood W. J., The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004 306 5700 1380 1383 2-s2.0-8844269161 10.1126/science.1103492 (Pubitemid 39532516)
304. Nukuzuma S., Nakamichi K., Nukuzuma C., Takegami T., Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells. Microbiology and Immunology 2009 53 9 496 501 2-s2.0-75749141317 10.1111/j.1348-0421.2009.00156.x
305. Altschuler E. L., Kast R. E., The atypical antipsychotic agents zisprasidone, risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Medical Hypotheses 2005 65 3 585 586 2-s2.0-21844455547 10.1016/j.mehy.2005.01.037 (Pubitemid 40956959)
306. Lanzafame M., Ferrari S., Lattuada E., Corsini F., Deganello R., Vento S., Concia E., Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy. Infezioni in Medicina 2009 17 1 35 37 2-s2.0-65649103403
307. Chapagain M. L., Sumibcay L., Gurjav U., Kaufusi P., Kast R. E., Nerurkar V. R., Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. Journal of NeuroVirology 2008 14 5 448 454 2-s2.0-57049189593 10.1080/13550280802235916 (Pubitemid 352762884)
308. Monaco M. C., Maric D., Bandeian A., Progenitor-derived Oligodendrocyte culture system from human fetal brain. Journal of Visualized Experiments 2012 70 e4274 10.3791/4274
309. Pöhlmann C., Hochauf K., Röllig C., Schetelig J., Wunderlich O., Bandt D., Ehninger G., Jacobs E., Rohayem J., Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy. Intervirology 2007 50 6 412 417 2-s2.0-39749191853 10.1159/000112916 (Pubitemid 351309882)
310. Brickelmaier M., Lugovskoy A., Kartikeyan R., Reviriego-Mendoza M. M., Allaire N., Simon K., Frisque R. J., Gorelik L., Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrobial Agents and Chemotherapy 2009 53 5 1840 1849 2-s2.0-66149083981 10.1128/AAC.01614-08
311. Gofton T. E., Al-Khotani A., O'Farrell B., Ang L. C., McLachlan R. S., Mefloquine in the treatment of progressive multifocal leukoencephalopathy. Journal of Neurology, Neurosurgery and Psychiatry 2011 82 4 452 455 2-s2.0-79952725168 10.1136/jnnp.2009.190652
312. Kishida S., Tanaka K., Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Internal Medicine 2010 49 22 2509 2513 2-s2.0-78549260749 10.2169/internalmedicine.49.3227
313. Bernhoff E., Tylden G. D., Kjerpeseth L. J., Gutteberg T. J., Hirsch H. H., Rinaldo C. H., Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. Journal of Virology 2010 84 4 2150 2156 2-s2.0-75449107430 10.1128/JVI.01737-09
314. Farasati N. A., Shapiro R., Vats A., Randhawa P., Effect of Leflunomide and Cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005 79 1 116 118 2-s2.0-12344300330 10.1097/01.TP.0000149338. 97084.5F (Pubitemid 40140009)
315. Josephson M. A., Gillen D., Javaid B., Kadambi P., Meehan S., Foster P., Harland R., Thistlethwaite R. J., Garfinkel M., Atwood W., Jordan J., Sadhu M., Millis M. J., Williams J., Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006 81 5 704 710 2-s2.0-33645067944 10.1097/01.tp.0000181149.76113.50
316. Faguer S., Hirsch H. H., Kamar N., Guilbeau-Frugier C., Ribes D., Guitard J., Esposito L., Cointault O., Modesto A., Lavit M., Mengelle C., Rostaing L., Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transplant International 2007 20 11 962 969 2-s2.0-35148839477 10.1111/j.1432-2277.2007.00523.x (Pubitemid 47537566)
317. Leca N., Muczynski K. A., Jefferson J. A., de Boer I. H., Kowalewska J., Kendrick E. A., Pichler R., Davis C. L., Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clinical Journal of the American Society of Nephrology 2008 3 3 829 835 2-s2.0-44649165198 10.2215/CJN.03930907
318. Guasch A., Roy-Chaudhury P., Woodle E. S., Fitzsimmons W., Holman J., First M. R., Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation 2010 90 8 891 897 2-s2.0-78349279503 10.1097/TP.0b013e3181f2c94b
319. Reilmann R., Imai T., Ringelstein E. B., Gaubitz M., Niederstadt T. U., Paulus W., Husstedt I. W., Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 9 1304 1305 2-s2.0-23944454095 10.1136/jnnp.2004.057588 (Pubitemid 41208392)
320. Kraemer C., Evers S., Nolting T., Arendt G., Husstedt I. W., Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy. Journal of Neurology 2008 255 4 526 531 2-s2.0-42549171604 10.1007/s00415-008-0731-z
321. Nicoli F., Chave B., Peragut J. C., Gastaut J. L., Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. The Lancet 1992 339 8788 306 2-s2.0-0026532693
322. Guarino M., D'Alessandro R., Rinaldi R., Stracciari A., Pazzaglia P., Costigliola P., Marinacci G., Chiodo F., Di Giandomenico G., Cancellieri C., Gritti F., Causarano R., Sterzi R., Villa M. R., Schiantarelli C., Cinque P., Motti L., Ghidoni E., Giudici M., Progressive multifocal leucoencephalopathy in AIDS: treatment with cytosine arabinoside. AIDS 1995 9 7 819 820 2-s2.0-0029062156
323. Moreno S., Miralles P., Díaz M. D., Berenguer J., De Quirós J. C. L. B., Blázquez R., Cosín J., Bouza E., Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. Clinical Infectious Diseases 1996 23 5 1066 1068 2-s2.0-0029910151 (Pubitemid 26367495)
324. Portolani M., Pietrosemoli P., Cermelli C., Mannini-Palenzona A., Grossi M. P., Paolini L., Barbanti-Brodano G., Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Research 1988 9 3 205 218 2-s2.0-0023901821 10.1016/0166-3542(88)90004-6
325. Ali S. H., Chandraker A., DeCaprio J. A., Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. Antiviral Therapy 2007 12 1 1 6 2-s2.0-33847347546 (Pubitemid 46340419)
326. Gabardi S., Waikar S. S., Martin S., Roberts K., Chen J., Borgi L., Sheashaa H., Dyer C., Malek S. K., Tullius S. G., Vadivel N., Grafals M., Abdi R., Najafian N., Milford E., Chandraker A., Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clinical Journal of the American Society of Nephrology 2010 5 7 1298 1304 2-s2.0-77954813434 10.2215/CJN.08261109
327. Wojciechowski D., Chanda R., Chandran S., Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 Year. Transplantation 2012 94 11 1117 1123
328. Miller A. N., Glode A., Hogan K. R., Schaub C., Kramer C., Stuart R. K., Costa L. J., Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation 2011 17 8 1176 1181 2-s2.0-79960224473 10.1016/j.bbmt.2010.12. 700
329. Liacini A., Seamone M. E., Muruve D. A., Tibbles L. A., Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation 2010 90 12 1450 1457 2-s2.0-78650826189 10.1097/TP.0b013e3182007be2
330. Sanchez Fructuoso A. I., Calvo N., Perez-Flores I., Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients. Transplant Infectious Disease 2011 13 6 584 591
331. Hymes L. C., Warshaw B. L., Five-year experience using sirolimus-based, calcineurin inhibitor-free immunosuppression in pediatric renal transplantation. Pediatric Transplantation 2011 15 4 437 441 2-s2.0-79957491390 10.1111/j.1399-3046.2011.01477.x